aluates Reports

$ 0.0

Automative

Global Postoperative Nausea and Vomiting Management Market Research Report 2025

Published Date: April 2025

Report Code: QYRE-Auto-2M14429

Global Postoperative Nausea and Vomiting Management Market Research Report 2023

BUY CHAPTERS

Global Postoperative Nausea and Vomiting Management Market Research Report 2025

Code: QYRE-Auto-2M14429

Report

April 2025

Pages:73

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Acacia Pharma

Roche

Novartis

Ani Pharmaceuticals Inc.

Camurus AB

Sanofi

Eisai Corporation

Merck and Co.

Helsinn Holding S.A.

GlaxoSmithKline PLC

Postoperative Nausea and Vomiting Management Market Size

The global market for Postoperative Nausea and Vomiting Management was valued at US$ 1298 million in the year 2024 and is projected to reach a revised size of US$ 2896 million by 2031, growing at a CAGR of 12.3% during the forecast period.

Postoperative Nausea and Vomiting Management Market

Postoperative nausea and vomiting (PONV) management refers to the various strategies and interventions used to prevent or treat nausea and vomiting in patients after surgery.

The postoperative nausea and vomiting (PONV) management market is driven by the increasing number of surgical procedures and the growing awareness about the adverse effects of PONV on patients" recovery and satisfaction. Anesthesia-induced nausea and vomiting are common complications after surgery, and effective PONV management is crucial to enhance patient outcomes and reduce healthcare costs associated with extended hospital stays and additional treatments. As a result, there is a rising demand for pharmacological and non-pharmacological interventions, such as antiemetic medications, acupressure, and enhanced recovery protocols, to prevent and alleviate PONV. However, the market also faces challenges, including the variability in individual patient responses to antiemetic treatments and the risk of adverse effects associated with certain medications. Additionally, the availability and affordability of effective PONV management options in different healthcare settings can vary, especially in resource-limited regions. Overcoming these challenges through ongoing research and innovation in PONV management approaches, personalized patient care, and education of healthcare professionals will be essential in driving the growth of the postoperative nausea and vomiting management market and improving the post-surgical experience for patients worldwide.

This report aims to provide a comprehensive presentation of the global market for Postoperative Nausea and Vomiting Management, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Postoperative Nausea and Vomiting Management.

The Postoperative Nausea and Vomiting Management market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Postoperative Nausea and Vomiting Management market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Postoperative Nausea and Vomiting Management companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Postoperative Nausea and Vomiting Management Market Report

Report Metric	Details
Report Name	Postoperative Nausea and Vomiting Management Market
Accounted market size in year	US$ 1298 million
Forecasted market size in 2031	US$ 2896 million
CAGR	12.3%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Serotonin Antagonists Steroids Dopamine Antagonists Neurokinin NK-1 Receptor Antagonists Non-pharmacological Treatment
Segment by Application	Hospital Pharmacies Online Pharmacies Retail Pharmacies and Drug Stores
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Acacia Pharma, Roche, Novartis AG, Ani Pharmaceuticals, Inc, Camurus AB, Sanofi S.A., Helsinn Holding S.A., Eisai Corporation, Merck and Co., GlaxoSmithKline
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Postoperative Nausea and Vomiting Management company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Postoperative Nausea and Vomiting Management Market growing?

Ans: The Postoperative Nausea and Vomiting Management Market witnessing a CAGR of 12.3% during the forecast period 2025-2031.

What is the Postoperative Nausea and Vomiting Management Market size in 2031?

Ans: The Postoperative Nausea and Vomiting Management Market size in 2031 will be US$ 2896 million.

Who are the main players in the Postoperative Nausea and Vomiting Management Market report?

Ans: The main players in the Postoperative Nausea and Vomiting Management Market are Acacia Pharma, Roche, Novartis AG, Ani Pharmaceuticals, Inc, Camurus AB, Sanofi S.A., Helsinn Holding S.A., Eisai Corporation, Merck and Co., GlaxoSmithKline

What are the Application segmentation covered in the Postoperative Nausea and Vomiting Management Market report?

Ans: The Applications covered in the Postoperative Nausea and Vomiting Management Market report are Hospital Pharmacies, Online Pharmacies, Retail Pharmacies and Drug Stores

What are the Type segmentation covered in the Postoperative Nausea and Vomiting Management Market report?

Ans: The Types covered in the Postoperative Nausea and Vomiting Management Market report are Serotonin Antagonists, Steroids, Dopamine Antagonists, Neurokinin NK-1 Receptor Antagonists, Non-pharmacological Treatment

Recommended Reports

Post-surgical Care

Operating Room Solutions

Anesthesia & Antiemetics

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Postoperative Nausea and Vomiting Management Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Serotonin Antagonists

1.2.3 Steroids

1.2.4 Dopamine Antagonists

1.2.5 Neurokinin NK-1 Receptor Antagonists

1.2.6 Non-pharmacological Treatment

1.3 Market by Application

1.3.1 Global Postoperative Nausea and Vomiting Management Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital Pharmacies

1.3.3 Online Pharmacies

1.3.4 Retail Pharmacies and Drug Stores

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Postoperative Nausea and Vomiting Management Market Perspective (2020-2031)

2.2 Global Postoperative Nausea and Vomiting Management Growth Trends by Region

2.2.1 Global Postoperative Nausea and Vomiting Management Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Postoperative Nausea and Vomiting Management Historic Market Size by Region (2020-2025)

2.2.3 Postoperative Nausea and Vomiting Management Forecasted Market Size by Region (2026-2031)

2.3 Postoperative Nausea and Vomiting Management Market Dynamics

2.3.1 Postoperative Nausea and Vomiting Management Industry Trends

2.3.2 Postoperative Nausea and Vomiting Management Market Drivers

2.3.3 Postoperative Nausea and Vomiting Management Market Challenges

2.3.4 Postoperative Nausea and Vomiting Management Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Postoperative Nausea and Vomiting Management Players by Revenue

3.1.1 Global Top Postoperative Nausea and Vomiting Management Players by Revenue (2020-2025)

3.1.2 Global Postoperative Nausea and Vomiting Management Revenue Market Share by Players (2020-2025)

3.2 Global Postoperative Nausea and Vomiting Management Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Postoperative Nausea and Vomiting Management Revenue

3.4 Global Postoperative Nausea and Vomiting Management Market Concentration Ratio

3.4.1 Global Postoperative Nausea and Vomiting Management Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Postoperative Nausea and Vomiting Management Revenue in 2024

3.5 Global Key Players of Postoperative Nausea and Vomiting Management Head office and Area Served

3.6 Global Key Players of Postoperative Nausea and Vomiting Management, Product and Application

3.7 Global Key Players of Postoperative Nausea and Vomiting Management, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Postoperative Nausea and Vomiting Management Breakdown Data by Type

4.1 Global Postoperative Nausea and Vomiting Management Historic Market Size by Type (2020-2025)

4.2 Global Postoperative Nausea and Vomiting Management Forecasted Market Size by Type (2026-2031)

5 Postoperative Nausea and Vomiting Management Breakdown Data by Application

5.1 Global Postoperative Nausea and Vomiting Management Historic Market Size by Application (2020-2025)

5.2 Global Postoperative Nausea and Vomiting Management Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Postoperative Nausea and Vomiting Management Market Size (2020-2031)

6.2 North America Postoperative Nausea and Vomiting Management Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Postoperative Nausea and Vomiting Management Market Size by Country (2020-2025)

6.4 North America Postoperative Nausea and Vomiting Management Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Postoperative Nausea and Vomiting Management Market Size (2020-2031)

7.2 Europe Postoperative Nausea and Vomiting Management Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Postoperative Nausea and Vomiting Management Market Size by Country (2020-2025)

7.4 Europe Postoperative Nausea and Vomiting Management Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Postoperative Nausea and Vomiting Management Market Size (2020-2031)

8.2 Asia-Pacific Postoperative Nausea and Vomiting Management Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Postoperative Nausea and Vomiting Management Market Size by Region (2020-2025)

8.4 Asia-Pacific Postoperative Nausea and Vomiting Management Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Postoperative Nausea and Vomiting Management Market Size (2020-2031)

9.2 Latin America Postoperative Nausea and Vomiting Management Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Postoperative Nausea and Vomiting Management Market Size by Country (2020-2025)

9.4 Latin America Postoperative Nausea and Vomiting Management Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Postoperative Nausea and Vomiting Management Market Size (2020-2031)

10.2 Middle East & Africa Postoperative Nausea and Vomiting Management Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Postoperative Nausea and Vomiting Management Market Size by Country (2020-2025)

10.4 Middle East & Africa Postoperative Nausea and Vomiting Management Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Acacia Pharma

11.1.1 Acacia Pharma Company Details

11.1.2 Acacia Pharma Business Overview

11.1.3 Acacia Pharma Postoperative Nausea and Vomiting Management Introduction

11.1.4 Acacia Pharma Revenue in Postoperative Nausea and Vomiting Management Business (2020-2025)

11.1.5 Acacia Pharma Recent Development

11.2 Roche

11.2.1 Roche Company Details

11.2.2 Roche Business Overview

11.2.3 Roche Postoperative Nausea and Vomiting Management Introduction

11.2.4 Roche Revenue in Postoperative Nausea and Vomiting Management Business (2020-2025)

11.2.5 Roche Recent Development

11.3 Novartis AG

11.3.1 Novartis AG Company Details

11.3.2 Novartis AG Business Overview

11.3.3 Novartis AG Postoperative Nausea and Vomiting Management Introduction

11.3.4 Novartis AG Revenue in Postoperative Nausea and Vomiting Management Business (2020-2025)

11.3.5 Novartis AG Recent Development

11.4 Ani Pharmaceuticals, Inc

11.4.1 Ani Pharmaceuticals, Inc Company Details

11.4.2 Ani Pharmaceuticals, Inc Business Overview

11.4.3 Ani Pharmaceuticals, Inc Postoperative Nausea and Vomiting Management Introduction

11.4.4 Ani Pharmaceuticals, Inc Revenue in Postoperative Nausea and Vomiting Management Business (2020-2025)

11.4.5 Ani Pharmaceuticals, Inc Recent Development

11.5 Camurus AB

11.5.1 Camurus AB Company Details

11.5.2 Camurus AB Business Overview

11.5.3 Camurus AB Postoperative Nausea and Vomiting Management Introduction

11.5.4 Camurus AB Revenue in Postoperative Nausea and Vomiting Management Business (2020-2025)

11.5.5 Camurus AB Recent Development

11.6 Sanofi S.A.

11.6.1 Sanofi S.A. Company Details

11.6.2 Sanofi S.A. Business Overview

11.6.3 Sanofi S.A. Postoperative Nausea and Vomiting Management Introduction

11.6.4 Sanofi S.A. Revenue in Postoperative Nausea and Vomiting Management Business (2020-2025)

11.6.5 Sanofi S.A. Recent Development

11.7 Helsinn Holding S.A.

11.7.1 Helsinn Holding S.A. Company Details

11.7.2 Helsinn Holding S.A. Business Overview

11.7.3 Helsinn Holding S.A. Postoperative Nausea and Vomiting Management Introduction

11.7.4 Helsinn Holding S.A. Revenue in Postoperative Nausea and Vomiting Management Business (2020-2025)

11.7.5 Helsinn Holding S.A. Recent Development

11.8 Eisai Corporation

11.8.1 Eisai Corporation Company Details

11.8.2 Eisai Corporation Business Overview

11.8.3 Eisai Corporation Postoperative Nausea and Vomiting Management Introduction

11.8.4 Eisai Corporation Revenue in Postoperative Nausea and Vomiting Management Business (2020-2025)

11.8.5 Eisai Corporation Recent Development

11.9 Merck and Co.

11.9.1 Merck and Co. Company Details

11.9.2 Merck and Co. Business Overview

11.9.3 Merck and Co. Postoperative Nausea and Vomiting Management Introduction

11.9.4 Merck and Co. Revenue in Postoperative Nausea and Vomiting Management Business (2020-2025)

11.9.5 Merck and Co. Recent Development

11.10 GlaxoSmithKline

11.10.1 GlaxoSmithKline Company Details

11.10.2 GlaxoSmithKline Business Overview

11.10.3 GlaxoSmithKline Postoperative Nausea and Vomiting Management Introduction

11.10.4 GlaxoSmithKline Revenue in Postoperative Nausea and Vomiting Management Business (2020-2025)

11.10.5 GlaxoSmithKline Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Acacia Pharma

Roche

Novartis

Ani Pharmaceuticals Inc.

Camurus AB

Sanofi

Eisai Corporation

Merck and Co.

Helsinn Holding S.A.

GlaxoSmithKline PLC

List of Tables

Table 1. Global Postoperative Nausea and Vomiting Management Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Serotonin Antagonists

Table 3. Key Players of Steroids

Table 4. Key Players of Dopamine Antagonists

Table 5. Key Players of Neurokinin NK-1 Receptor Antagonists

Table 6. Key Players of Non-pharmacological Treatment

Table 7. Global Postoperative Nausea and Vomiting Management Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Postoperative Nausea and Vomiting Management Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Postoperative Nausea and Vomiting Management Market Size by Region (2020-2025) & (US$ Million)

Table 10. Global Postoperative Nausea and Vomiting Management Market Share by Region (2020-2025)

Table 11. Global Postoperative Nausea and Vomiting Management Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 12. Global Postoperative Nausea and Vomiting Management Market Share by Region (2026-2031)

Table 13. Postoperative Nausea and Vomiting Management Market Trends

Table 14. Postoperative Nausea and Vomiting Management Market Drivers

Table 15. Postoperative Nausea and Vomiting Management Market Challenges

Table 16. Postoperative Nausea and Vomiting Management Market Restraints

Table 17. Global Postoperative Nausea and Vomiting Management Revenue by Players (2020-2025) & (US$ Million)

Table 18. Global Postoperative Nausea and Vomiting Management Market Share by Players (2020-2025)

Table 19. Global Top Postoperative Nausea and Vomiting Management Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Postoperative Nausea and Vomiting Management as of 2024)

Table 20. Ranking of Global Top Postoperative Nausea and Vomiting Management Companies by Revenue (US$ Million) in 2024

Table 21. Global 5 Largest Players Market Share by Postoperative Nausea and Vomiting Management Revenue (CR5 and HHI) & (2020-2025)

Table 22. Global Key Players of Postoperative Nausea and Vomiting Management, Headquarters and Area Served

Table 23. Global Key Players of Postoperative Nausea and Vomiting Management, Product and Application

Table 24. Global Key Players of Postoperative Nausea and Vomiting Management, Date of Enter into This Industry

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Postoperative Nausea and Vomiting Management Market Size by Type (2020-2025) & (US$ Million)

Table 27. Global Postoperative Nausea and Vomiting Management Revenue Market Share by Type (2020-2025)

Table 28. Global Postoperative Nausea and Vomiting Management Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 29. Global Postoperative Nausea and Vomiting Management Revenue Market Share by Type (2026-2031)

Table 30. Global Postoperative Nausea and Vomiting Management Market Size by Application (2020-2025) & (US$ Million)

Table 31. Global Postoperative Nausea and Vomiting Management Revenue Market Share by Application (2020-2025)

Table 32. Global Postoperative Nausea and Vomiting Management Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 33. Global Postoperative Nausea and Vomiting Management Revenue Market Share by Application (2026-2031)

Table 34. North America Postoperative Nausea and Vomiting Management Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. North America Postoperative Nausea and Vomiting Management Market Size by Country (2020-2025) & (US$ Million)

Table 36. North America Postoperative Nausea and Vomiting Management Market Size by Country (2026-2031) & (US$ Million)

Table 37. Europe Postoperative Nausea and Vomiting Management Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 38. Europe Postoperative Nausea and Vomiting Management Market Size by Country (2020-2025) & (US$ Million)

Table 39. Europe Postoperative Nausea and Vomiting Management Market Size by Country (2026-2031) & (US$ Million)

Table 40. Asia-Pacific Postoperative Nausea and Vomiting Management Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 41. Asia-Pacific Postoperative Nausea and Vomiting Management Market Size by Region (2020-2025) & (US$ Million)

Table 42. Asia-Pacific Postoperative Nausea and Vomiting Management Market Size by Region (2026-2031) & (US$ Million)

Table 43. Latin America Postoperative Nausea and Vomiting Management Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Latin America Postoperative Nausea and Vomiting Management Market Size by Country (2020-2025) & (US$ Million)

Table 45. Latin America Postoperative Nausea and Vomiting Management Market Size by Country (2026-2031) & (US$ Million)

Table 46. Middle East & Africa Postoperative Nausea and Vomiting Management Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 47. Middle East & Africa Postoperative Nausea and Vomiting Management Market Size by Country (2020-2025) & (US$ Million)

Table 48. Middle East & Africa Postoperative Nausea and Vomiting Management Market Size by Country (2026-2031) & (US$ Million)

Table 49. Acacia Pharma Company Details

Table 50. Acacia Pharma Business Overview

Table 51. Acacia Pharma Postoperative Nausea and Vomiting Management Product

Table 52. Acacia Pharma Revenue in Postoperative Nausea and Vomiting Management Business (2020-2025) & (US$ Million)

Table 53. Acacia Pharma Recent Development

Table 54. Roche Company Details

Table 55. Roche Business Overview

Table 56. Roche Postoperative Nausea and Vomiting Management Product

Table 57. Roche Revenue in Postoperative Nausea and Vomiting Management Business (2020-2025) & (US$ Million)

Table 58. Roche Recent Development

Table 59. Novartis AG Company Details

Table 60. Novartis AG Business Overview

Table 61. Novartis AG Postoperative Nausea and Vomiting Management Product

Table 62. Novartis AG Revenue in Postoperative Nausea and Vomiting Management Business (2020-2025) & (US$ Million)

Table 63. Novartis AG Recent Development

Table 64. Ani Pharmaceuticals, Inc Company Details

Table 65. Ani Pharmaceuticals, Inc Business Overview

Table 66. Ani Pharmaceuticals, Inc Postoperative Nausea and Vomiting Management Product

Table 67. Ani Pharmaceuticals, Inc Revenue in Postoperative Nausea and Vomiting Management Business (2020-2025) & (US$ Million)

Table 68. Ani Pharmaceuticals, Inc Recent Development

Table 69. Camurus AB Company Details

Table 70. Camurus AB Business Overview

Table 71. Camurus AB Postoperative Nausea and Vomiting Management Product

Table 72. Camurus AB Revenue in Postoperative Nausea and Vomiting Management Business (2020-2025) & (US$ Million)

Table 73. Camurus AB Recent Development

Table 74. Sanofi S.A. Company Details

Table 75. Sanofi S.A. Business Overview

Table 76. Sanofi S.A. Postoperative Nausea and Vomiting Management Product

Table 77. Sanofi S.A. Revenue in Postoperative Nausea and Vomiting Management Business (2020-2025) & (US$ Million)

Table 78. Sanofi S.A. Recent Development

Table 79. Helsinn Holding S.A. Company Details

Table 80. Helsinn Holding S.A. Business Overview

Table 81. Helsinn Holding S.A. Postoperative Nausea and Vomiting Management Product

Table 82. Helsinn Holding S.A. Revenue in Postoperative Nausea and Vomiting Management Business (2020-2025) & (US$ Million)

Table 83. Helsinn Holding S.A. Recent Development

Table 84. Eisai Corporation Company Details

Table 85. Eisai Corporation Business Overview

Table 86. Eisai Corporation Postoperative Nausea and Vomiting Management Product

Table 87. Eisai Corporation Revenue in Postoperative Nausea and Vomiting Management Business (2020-2025) & (US$ Million)

Table 88. Eisai Corporation Recent Development

Table 89. Merck and Co. Company Details

Table 90. Merck and Co. Business Overview

Table 91. Merck and Co. Postoperative Nausea and Vomiting Management Product

Table 92. Merck and Co. Revenue in Postoperative Nausea and Vomiting Management Business (2020-2025) & (US$ Million)

Table 93. Merck and Co. Recent Development

Table 94. GlaxoSmithKline Company Details

Table 95. GlaxoSmithKline Business Overview

Table 96. GlaxoSmithKline Postoperative Nausea and Vomiting Management Product

Table 97. GlaxoSmithKline Revenue in Postoperative Nausea and Vomiting Management Business (2020-2025) & (US$ Million)

Table 98. GlaxoSmithKline Recent Development

Table 99. Research Programs/Design for This Report

Table 100. Key Data Information from Secondary Sources

Table 101. Key Data Information from Primary Sources

Table 102. Authors List of This Report

List of Figures

Figure 1. Postoperative Nausea and Vomiting Management Picture

Figure 2. Global Postoperative Nausea and Vomiting Management Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Postoperative Nausea and Vomiting Management Market Share by Type: 2024 VS 2031

Figure 4. Serotonin Antagonists Features

Figure 5. Steroids Features

Figure 6. Dopamine Antagonists Features

Figure 7. Neurokinin NK-1 Receptor Antagonists Features

Figure 8. Non-pharmacological Treatment Features

Figure 9. Global Postoperative Nausea and Vomiting Management Market Size by Application (2020-2031) & (US$ Million)

Figure 10. Global Postoperative Nausea and Vomiting Management Market Share by Application: 2024 VS 2031

Figure 11. Hospital Pharmacies Case Studies

Figure 12. Online Pharmacies Case Studies

Figure 13. Retail Pharmacies and Drug Stores Case Studies

Figure 14. Postoperative Nausea and Vomiting Management Report Years Considered

Figure 15. Global Postoperative Nausea and Vomiting Management Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global Postoperative Nausea and Vomiting Management Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Postoperative Nausea and Vomiting Management Market Share by Region: 2024 VS 2031

Figure 18. Global Postoperative Nausea and Vomiting Management Market Share by Players in 2024

Figure 19. Global Top Postoperative Nausea and Vomiting Management Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Postoperative Nausea and Vomiting Management as of 2024)

Figure 20. The Top 10 and 5 Players Market Share by Postoperative Nausea and Vomiting Management Revenue in 2024

Figure 21. North America Postoperative Nausea and Vomiting Management Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America Postoperative Nausea and Vomiting Management Market Share by Country (2020-2031)

Figure 23. United States Postoperative Nausea and Vomiting Management Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada Postoperative Nausea and Vomiting Management Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Postoperative Nausea and Vomiting Management Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Postoperative Nausea and Vomiting Management Market Share by Country (2020-2031)

Figure 27. Germany Postoperative Nausea and Vomiting Management Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France Postoperative Nausea and Vomiting Management Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. Postoperative Nausea and Vomiting Management Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy Postoperative Nausea and Vomiting Management Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia Postoperative Nausea and Vomiting Management Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries Postoperative Nausea and Vomiting Management Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Postoperative Nausea and Vomiting Management Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Postoperative Nausea and Vomiting Management Market Share by Region (2020-2031)

Figure 35. China Postoperative Nausea and Vomiting Management Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan Postoperative Nausea and Vomiting Management Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea Postoperative Nausea and Vomiting Management Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia Postoperative Nausea and Vomiting Management Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India Postoperative Nausea and Vomiting Management Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia Postoperative Nausea and Vomiting Management Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Postoperative Nausea and Vomiting Management Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Postoperative Nausea and Vomiting Management Market Share by Country (2020-2031)

Figure 43. Mexico Postoperative Nausea and Vomiting Management Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil Postoperative Nausea and Vomiting Management Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Postoperative Nausea and Vomiting Management Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Postoperative Nausea and Vomiting Management Market Share by Country (2020-2031)

Figure 47. Turkey Postoperative Nausea and Vomiting Management Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Postoperative Nausea and Vomiting Management Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE Postoperative Nausea and Vomiting Management Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Acacia Pharma Revenue Growth Rate in Postoperative Nausea and Vomiting Management Business (2020-2025)

Figure 51. Roche Revenue Growth Rate in Postoperative Nausea and Vomiting Management Business (2020-2025)

Figure 52. Novartis AG Revenue Growth Rate in Postoperative Nausea and Vomiting Management Business (2020-2025)

Figure 53. Ani Pharmaceuticals, Inc Revenue Growth Rate in Postoperative Nausea and Vomiting Management Business (2020-2025)

Figure 54. Camurus AB Revenue Growth Rate in Postoperative Nausea and Vomiting Management Business (2020-2025)

Figure 55. Sanofi S.A. Revenue Growth Rate in Postoperative Nausea and Vomiting Management Business (2020-2025)

Figure 56. Helsinn Holding S.A. Revenue Growth Rate in Postoperative Nausea and Vomiting Management Business (2020-2025)

Figure 57. Eisai Corporation Revenue Growth Rate in Postoperative Nausea and Vomiting Management Business (2020-2025)

Figure 58. Merck and Co. Revenue Growth Rate in Postoperative Nausea and Vomiting Management Business (2020-2025)

Figure 59. GlaxoSmithKline Revenue Growth Rate in Postoperative Nausea and Vomiting Management Business (2020-2025)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Postoperative Pain Control Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Postoperative Pain Therapeutics Market Insights Forecast to 2030

Global Chemotherapy induced Nausea and Vomiting Treatment Market Research Report 2025

Global Chemotherapy Induced Nausea and Vomiting CINV Drugs Market Insights Forecast to 2030

Global Treatment of Chemotherapy Induced Nausea in Cancer Patients Market Research Report 2025

Global Chemotheraphy Induced Nausea and Vomitting CINV Drugs Market Insights Forecast to 2030

Global Scopolamine Market Insights Forecast to 2030

Global Nausea And Vomiting Treatment Market Insights Forecast to 2030

Global Anti Nausea and Vomiting Healthcare Device Market Research Report 2024

Antiemetic Patch Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Postoperative Local Pain Relief System Market Research Report 2025

Global Postoperative Pain Management Market Research Report 2024

Postoperative Pain Control Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Non Medical Anti Nausea and Vomiting Device Market Research Report 2025

Global Postoperative Pain Therapeutics Service Market Insights Forecast to 2030

Global Anti Nausea and Vomiting Device Market Research Report 2024

Surgical Anaesthesia Information Management Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Electronic Antiemetic Device Market Research Report 2024

Global Medical Electronic Antiemetic Device Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions